ELVN Stock: Price, Earnings History and SEC Filings
Enliven Therapeutics, Inc. (ELVN) last traded at $44.25, down 1.84% on the latest session and down 3.5% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.49 against an analyst estimate of $-0.38, a miss of 28.9%.
$44.25 -1.84%
1 month-3.47%
52-week high$62.32
52-week low$14.79
Volume1.24M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ELVN earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 5, 2026 | $-0.49 | $-0.38 | -28.95% |
| Mar 2026 | May 7, 2026 | $-0.38 | $-0.44 | +13.64% |
| Dec 2025 | Mar 3, 2026 | $-0.48 | $-0.42 | -14.29% |
| Sep 2025 | Nov 12, 2025 | $-0.32 | $-0.43 | +25.58% |
ELVN beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for ELVN
SEC filing data is not available right now. You can search for ELVN on SEC EDGAR.
ELVN news
No recent headlines found. The live terminal has the full news feed.
About Enliven Therapeutics, Inc.
Enliven Therapeutics, Inc. (ELVN) is a US-listed public company on Nasdaq.